Prevalence and predictors of anti-infective use during pregnancy

Pharmacoepidemiology and Drug Safety
Fabiano SantosAnick Bérard

Abstract

(1) Measure the prevalence and trends of anti-infective drug use before, during, and after pregnancy; (2) to list the doses, classes, types, and indications for anti-infective use during pregnancy; and (3) to identify predictors associated with anti-infective drug use during pregnancy. Retrospective cohort study within the Quebec Pregnancy Registry, which was created by the linkage of three administrative databases: RAMQ, Méd-Echo, and ISQ. Women were eligible if they were (1) continuously insured by the RAMQ drug plan for at least 12 months before the first day of gestation, during pregnancy and 12 months after the end of the pregnancy and (2) if they gave birth to a live born between January 1998 and December 2003. Ninety-seven thousand six hundred and eighty pregnant women met the eligibility criteria. Data were collected for systemic agents. Logistic regression models were used to quantify predictors of use. Prevalence of anti-infective use during pregnancy was 24.5%. Penicillins use increased compared to other classes. The most frequently diagnosed infections were respiratory and urinary tract infections. Predictors associated with use at the beginning of gestation were having > or =2 different prescribers [OR = 3.83 (95% ...Continue Reading

References

Mar 1, 1991·The Medical Clinics of North America·V T Andriole, T F Patterson
Nov 28, 1987·Lancet·R Wise
Feb 1, 1994·Genitourinary Medicine·H MacDougall
May 1, 1997·Southern Medical Journal·M Y SplinterW F Rayburn
Sep 1, 1997·Obstetrics and Gynecology Clinics of North America·J S Dashe, L C Gilstrap
May 26, 1998·JAMA : the Journal of the American Medical Association·J AvornJ LeLorier
Dec 10, 1998·European Journal of Obstetrics, Gynecology, and Reproductive Biology·A E CzeizelJ Olsen
May 21, 1999·European Journal of Clinical Pharmacology·C OlesenH T Sørensen
Aug 5, 2000·The Australian & New Zealand Journal of Obstetrics & Gynaecology·A Henry, C Crowther
Aug 4, 2005·Die Pharmazie·F Sá del FiolF C Groppo
Jun 1, 2006·BMC Pregnancy and Childbirth·Moumita SarkarAdrienne R N Einarson
Jun 21, 2006·Seminars in Fetal & Neonatal Medicine·Kjersti M Aagaard-TilleryJess Dalton
Dec 6, 2006·The Urologic Clinics of North America·Amanda M Macejko, Anthony J Schaeffer
Jan 12, 2007·British Journal of Clinical Pharmacology·Anick BérardDriss Oraichi
Feb 8, 2007·Emerging Infectious Diseases·Denise J JamiesonSonja A Rasmussen
Apr 28, 2007·Expert Reviews in Molecular Medicine·Ana Claudia ZenclussenHans-Dieter Volk
Jun 15, 2007·BJOG : an International Journal of Obstetrics and Gynaecology·E RamosA Bérard
Aug 24, 2007·Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'obstétrique Et Gynécologie Du Canada : JOGC·Dena L SchanzerTheresa W S Tam
Nov 27, 2007·British Dental Journal·G J Bateman, S Saha
Mar 18, 2008·Statistics in Medicine·G Niklas NorénI Ralph Edwards
Sep 2, 2008·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Benjamin Bar-OzAsher Ornoy
Jan 27, 2009·European Journal of Clinical Pharmacology·Marie-Pierre GendronAnick Bérard
Feb 4, 2009·Cleveland Clinic Journal of Medicine·Paul S Gibson, Raymond Powrie

❮ Previous
Next ❯

Citations

Jul 14, 2011·BJOG : an International Journal of Obstetrics and Gynaecology·F SantosA Berard
Nov 26, 2015·Pharmacotherapy·P Brandon BookstaverMilena McLaughlin
Sep 29, 2015·BJOG : an International Journal of Obstetrics and Gynaecology·M B AzadUNKNOWN CHILD Study Investigators
Oct 16, 2014·BJOG : an International Journal of Obstetrics and Gynaecology·I M ZomerdijkB H Stricker
Dec 18, 2018·The Annals of Pharmacotherapy·Hana RacP Brandon Bookstaver
Apr 22, 2018·The European Respiratory Journal·Keely LoewenMeghan B Azad
Jun 9, 2019·Journal of Autism and Developmental Disorders·Jan ŁukasikUNKNOWN SAWANTI Working Group
Jan 30, 2018·Frontiers in Microbiology·Lucy L FurfaroMatthew S Payne
Nov 16, 2019·British Journal of Clinical Pharmacology·Flory Tsobo MuandaAnick Bérard
Jan 23, 2018·Frontiers in Medicine·Louise C Kenny, Douglas B Kell
Apr 18, 2017·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Mario PassaroGiancarlo Balbi
Sep 5, 2017·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·C MannucciG Calapai
Dec 19, 2020·Microorganisms·Mohammed AmirMelody Y Zeng
Jul 1, 2021·Health SA = SA Gesondheid·Sasha NaidooFrasia Oosthuizen
Jul 29, 2021·Pediatric Pulmonology·Fanny E M GothInger M Jørgensen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.